Jiangning District Nanjing, China

Tian Lv

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Nanjing Heron Pharmaceutical Science and Technology Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tian Lv. Retrieved from https://idiyas.com/inventor/tian-lv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tian Lv - Innovator in Pharmaceutical Science

Introduction

Tian Lv is an inventor based in Nanjing, China. He is currently associated with Nanjing Heron Pharmaceutical Science and Technology Co., Ltd. Despite having no granted patents to his name, he is actively involved in the development of innovative pharmaceutical compositions.

Latest Patent Applications

Tian Lv has submitted several notable patent applications. One of his latest applications is for a ketorolaco derivative, which demonstrates improved half-life and stability, along with enhanced pharmacokinetic properties. This invention addresses the common issues associated with traditional ketorolaco preparations, such as frequent administration and gastrointestinal side effects. Another significant application is for an arylpropionic acid derivative, which also showcases favorable pharmacokinetic properties and stability. This derivative aims to improve patient compliance by reducing the side effects typically associated with nonsteroidal anti-inflammatory drugs.

Conclusion

Tian Lv is making strides in the pharmaceutical field through his innovative applications, focusing on enhancing drug efficacy and patient compliance. His work reflects a commitment to addressing the challenges faced in traditional medication formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…